ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

POLX Polarean Imaging Plc

3.75
0.00 (0.00%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Polarean Imaging Plc LSE:POLX London Ordinary Share GB00BF3DT583 ORD GBP0.00037
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.75 3.70 3.80 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Surgical,med Instr,apparatus 1.03M -13.91M -0.0644 -0.58 8.09M
Polarean Imaging Plc is listed in the Surgical,med Instr,apparatus sector of the London Stock Exchange with ticker POLX. The last closing price for Polarean Imaging was 3.75p. Over the last year, Polarean Imaging shares have traded in a share price range of 3.70p to 32.25p.

Polarean Imaging currently has 215,848,593 shares in issue. The market capitalisation of Polarean Imaging is £8.09 million. Polarean Imaging has a price to earnings ratio (PE ratio) of -0.58.

Polarean Imaging Share Discussion Threads

Showing 6326 to 6346 of 6500 messages
Chat Pages: 260  259  258  257  256  255  254  253  252  251  250  249  Older
DateSubjectAuthorDiscuss
03/3/2024
21:51
No Investor presentation - no questions and no answers.
a free run for the Directors.

If 150 million shares are issued and nukem take 50 and Bracco 40 they will end up with just about 35% of the company. Is that by chance or very clever?

is it any wonder that asset managers question the destruction of the share price since the last fund raise back as far as the IPO.
UK Institutional investors need to be more active.


The Chairman and board refuse to market in the UK to NHS or Private Health Care.
They have no difficulty in applying for a UK grant of several million to fund their activity in the USA.

The sales forecast in the USA for the next two years is dreadful.

A reminder that this Chairman and Board of Directors including Nukem are not fit for purpose and are directly responsible for the poor sales forecasts , commercial strategy, commercial traction and the current state of the company and share price.

goldbutler
03/3/2024
21:46
Explain please
bloomberg2
03/3/2024
11:32
Radiation Costly Doesn't illustrate ventilation additionally
moontheloon
03/3/2024
09:13
From a bicycle to a Porsche: super-scanners that could come to NHShttps://www.thetimes.co.uk/article/d423a493-29bb-4337-b8c8-5e76e624524b?shareToken=5b8a03783a4fa570bd057043df2f2dbd
bloomberg2
29/2/2024
20:36
Absolute BS Boney
john henry
29/2/2024
18:41
No I'm out at present Took a small hit a few weeks ago I'm watching for now
amaretto1
29/2/2024
18:11
Still in amaretto
moontheloon
29/2/2024
17:12
John Henry as for AGL I'm on eof a very select few individuals who ha made money on AGL.. My average was 15p and I sold at 31p so my entirety holding is now free after the spike.

Can't say the same for you with dest and wvey other share you call wrong

As for Polx the placing is going to wipe shareholders out pretty much and it will never recover. It will need nakther fund raise or two after this one too before it ever gets close to break even. Its game over despite how desperate the tmaoers try now

bones698
29/2/2024
17:06
No mention at all of UK, EU or other Non-US commercial opportunities.
That’s disappointing.

wetdream
29/2/2024
13:56
Polarean Imaging - the science behind the lung imaging tech is sound and the company is massively depressed. While a riskier investment, the upside could be massive if you time it right.
moontheloon
29/2/2024
13:45
https://www.share-talk.com/the-buyout-targets-of-2024/Buys piling in from the way overdone. Gla.
moontheloon
29/2/2024
11:28
https://www.proactiveinvestors.co.uk/companies/news/1042069/polarean-imaging-outlines-ambitious-investment-plans-as-it-looks-to-commercialise-xenoview-1042069.html?viewSource=TwitterUK
moontheloon
29/2/2024
10:51
Yup - PATT - you've been stupendously right to date. I'm still hopeful RE: AGL but your bearish stance there has me worried also.
nigelpm
29/2/2024
10:31
Last company von jako was involved with developing the product and company and resulted in a sale as a 200m sale . A sale has always been an option. We have demonstrated we have the time sorted. We have demonstrated we have willing backers. Prepared to back with hard cash. As am I. Dyor. I've done mine the Duke full system upgrade will be with us soon. Which will further demonstrate commercial traction.
moontheloon
29/2/2024
10:30
Yup - spot on PATT. I'm stunned it's not down to 2/3p - shows there's still a lot of naïve folk out there.
nigelpm
29/2/2024
10:26
RHatton reason why previous CEO was given the boot. Von Jako imho is far far more superior and capable in the CEO role.
john henry
29/2/2024
10:23
Moon you are literally clueless.. if only I could be bothered to post some of the email exchanges I had in 2022 with the previous ceo.. I’m not sure they are all that clued up
rhatton
29/2/2024
10:22
And guess what Moon - time = money when you are burning c.$0.8m a month
nigelpm
29/2/2024
10:15
Extended runway with current cash. And financing to support ongoing business.Keen happy very supportive financial and strategic support they know more than you my friend. And they know that these things take time in the medical sector. And they're happy with that. And hence i am.
moontheloon
29/2/2024
10:15
Strange how you dont mention AGL Boney where youve got that one completely wrong.
john henry
29/2/2024
10:08
It's not wrong. They gone slower than the market wanted but They've achieved everything they wanted albeit slower. Time is the only negative here.
moontheloon
Chat Pages: 260  259  258  257  256  255  254  253  252  251  250  249  Older

Your Recent History

Delayed Upgrade Clock